%22%3E%3Cstop%20offset%3D%220%25%22%20stop-color%3D%22%23451a03%22%2F%3E%3Cstop%20offset%3D%22100%25%22%20stop-color%3D%22%23d97706%22%20stop-opacity%3D%220.6%22%2F%3E%3C%2FlinearGradient%3E%3C%2Fdefs%3E%3Crect%20width%3D%22800%22%20height%3D%22200%22%20fill%3D%22url(%23bg)%22%2F%3E%3Ccircle%20cx%3D%22235%22%20cy%3D%2240%22%20r%3D%22162%22%20fill%3D%22%23d97706%22%20opacity%3D%220.32%22%2F%3E%3Ccircle%20cx%3D%22683%22%20cy%3D%22161%22%20r%3D%2268%22%20fill%3D%22%23d97706%22%20opacity%3D%220.29%22%2F%3E%3Ccircle%20cx%3D%22385%22%20cy%3D%22124%22%20r%3D%22173%22%20fill%3D%22%23d97706%22%20opacity%3D%220.18%22%2F%3E%3Cpolygon%20points%3D%2292%2C44%2049%2C44%2066%2C34%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.23%22%2F%3E%3Cpolygon%20points%3D%22269%2C79%20280%2C79%20265%2C95%22%20fill%3D%22%23d97706%22%20opacity%3D%220.33%22%2F%3E%3Cpolygon%20points%3D%22590%2C102%20568%2C62%20585%2C70%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.23%22%2F%3E%3Ccircle%20cx%3D%2244%22%20cy%3D%2247%22%20r%3D%2239%22%20fill%3D%22none%22%20stroke%3D%22%23d97706%22%20stroke-width%3D%224.5%22%20opacity%3D%220.33%22%2F%3E%3Cpolygon%20points%3D%22710%2C22%20730%2C51%20686%2C27%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.31%22%2F%3E%3Ccircle%20cx%3D%22603%22%20cy%3D%22101%22%20r%3D%224%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.65%22%2F%3E%3Ccircle%20cx%3D%22258%22%20cy%3D%2297%22%20r%3D%227%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.52%22%2F%3E%3Ccircle%20cx%3D%2282%22%20cy%3D%229%22%20r%3D%222%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.60%22%2F%3E%3Ccircle%20cx%3D%22222%22%20cy%3D%2293%22%20r%3D%226%22%20fill%3D%22%23fcd34d%22%20opacity%3D%220.67%22%2F%3E%3C%2Fsvg%3E)
Overview
PsyDAO is a DeSci DAO funding psychedelics research for mental health applications. Part of the Bio Protocol network, PsyDAO uses decentralized funding mechanisms to support research into psilocybin, MDMA, and other psychedelic compounds.
PsyDAO is a DeSci DAO funding psychedelics research for mental health applications. Part of the Bio Protocol network, PsyDAO uses decentralized funding mechanisms to support research into psilocybin, MDMA, and other psychedelic compounds.